+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
Obstructive Sleep Apnea - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Obstructive Sleep Apnea - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 339 Pages
  • Global
From
Hyperthyroidism - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hyperthyroidism - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 117 Pages
  • Global
From
Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 1389 Pages
  • Global
From
Tourette Syndrome - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Tourette Syndrome - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 138 Pages
  • Global
From
Febrile Neutropenia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Febrile Neutropenia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 201 Pages
  • Global
From
From
Hepatitis C Therapeutics: Competitive Landscape - Product Thumbnail Image

Hepatitis C Therapeutics: Competitive Landscape

  • Report
  • December 2024
  • 84 Pages
  • Global
From
Rett Syndrome: Competitive Landscape - Product Thumbnail Image

Rett Syndrome: Competitive Landscape

  • Report
  • December 2024
  • 66 Pages
  • Global
From
Acute-on-Chronic Liver Failure: Competitive Landscape - Product Thumbnail Image

Acute-on-Chronic Liver Failure: Competitive Landscape

  • Report
  • December 2024
  • 66 Pages
  • Global
From
Hepatitis B Therapeutics: Competitive Landscape - Product Thumbnail Image

Hepatitis B Therapeutics: Competitive Landscape

  • Report
  • November 2024
  • 78 Pages
  • Global
From
Glomerulonephritis: Competitive Landscape - Product Thumbnail Image

Glomerulonephritis: Competitive Landscape

  • Report
  • November 2024
  • 73 Pages
  • Global
From
Glaucoma: Epidemiology Forecast to 2033 - Product Thumbnail Image

Glaucoma: Epidemiology Forecast to 2033

  • Report
  • October 2024
  • 43 Pages
  • Global
From
Opioid Addiction: Opportunity Assessment and Forecast - Product Thumbnail Image

Opioid Addiction: Opportunity Assessment and Forecast

  • Report
  • October 2024
  • 80 Pages
  • Global
From
Neurofibromatoses: Competitive Landscape - Product Thumbnail Image

Neurofibromatoses: Competitive Landscape

  • Report
  • October 2024
  • 70 Pages
  • Global
From
Epidermolysis Bullosa: Competitive Landscape - Product Thumbnail Image

Epidermolysis Bullosa: Competitive Landscape

  • Report
  • October 2024
  • 69 Pages
  • Global
From
Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape - Product Thumbnail Image

Limb-Girdle Muscular Dystrophy (LGMD): Competitive Landscape

  • Report
  • October 2024
  • 65 Pages
  • Global
From
Gonorrhea (GN): Competitive Landscape - Product Thumbnail Image

Gonorrhea (GN): Competitive Landscape

  • Report
  • September 2024
  • 78 Pages
  • Global
From
Multiple System Atrophy (MSA): Competitive Landscape - Product Thumbnail Image

Multiple System Atrophy (MSA): Competitive Landscape

  • Report
  • September 2024
  • 63 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more